Comparison of Premixed Human Insulin 30/70 to Biphasic Aspart 30 in Well-Controlled Patients with Type 2 Diabetes Using Continuous Glucose Monitoring

Comparison of Premixed Human Insulin 30/70 to Biphasic Aspart 30 in Well-Controlled Patients with Type 2 Diabetes Using Continuous Glucose Monitoring

Aim: To compare in terms of glycemic variability two premixed insulins, Premixed Human Insulin 30/70 (PHI) and Biphasic Aspart 30 (BiAsp30), using Continuous Glucose Monitoring (CGM) and to estimate the correlation of Glycated Albumin (GA) and Fructosamine (FA) with CGM data. Patients-Data: A total...

Full description

Bibliographic Details
Main Authors: Charalampos Margaritidis, Eleni Karlafti, Evangelia Kotzakioulafi, Konstantinos Kantartzis, Konstantinos Tziomalos, Georgia Kaiafa, Christos Savopoulos, Triantafyllos Didangelos
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Journal of Clinical Medicine
Subjects:
diabetes mellitus 2
continuous glucose monitoring
premixed human insulin
premixed insulin analog
glycated albumin
fructosamine
Online Access:https://www.mdpi.com/2077-0383/10/9/1982

Internet

https://www.mdpi.com/2077-0383/10/9/1982

Similar Items